This was our first webinar of the Stakeholder Network that has evolved out of the Thematic Network of the same name. The objective of this event is to assess what can be done to identify and implement best practices in CRC screening in Europe in light of the COVID-19 pandemic.
REGISTER
During the webinar we will explore:
- How to make screening more robust and clinically effective when challenged by acute crisis such as the COVID pandemic
- Which stakeholders to involve and how to collaborate for maximum impact and efficiency
- How to ensure the development of more resilient and effective national screening programmes
- How to collaborate at EU level to share best practices and harmonise approaches.
AGENDA
Time (CET) |
Title |
Speakers |
|---|---|---|
| 10:00 – 10:05 | Welcome! See the slides | Dora Constantinides, Chair of the Board of Directors, DiCE |
| 10:05 – 10:15 |
Session introduction |
Prof. Dr. Eric Van Cutsem, Head of Digestive Oncology, Leuven University Hospital, Belgium and Member of the Board of Digestive Cancers Europe |
| 10:15 – 10:30 | European Commission: The Cancer Team | TBD |
| 10:30 – 10:40 |
CRC screening programmes in Europe under COVID-19 |
Dr. Carlo Senore, Centro Prevenzione Oncologica Regione Piemonte and Azienda Ospedaliero-Universitaria S Giovanni Battista di Torino, Turin, Italy |
| 10:40 – 10:50 |
Screening under COVID-19 in the Netherlands |
Dr. Iris Lansdorp-Vogelaar, Associate Professor at the Department of Public Health of Erasmus Medical Center, Rotterdam, Netherlands, and representing EU-TOPIA. |
| 10:50 – 11:00 | The Impact of the Covid 19 pandemic on the Screening Programme in Slovenia See the slides | Tit Albreht, MD, PhD, Senior Researcher, Joint Action Scientific Coordinator, National Institute of Public Health, Slovenia |
| 11:00 – 11:10 | Screening under Covid-19 in Finland See the slides | Dr Tytti Sarkeala, Director of Screening, PhD Finnish Cancer Registry Finland |
| 11:10 – 11:20 | How can the lessons learned help us cope with future crises and / or improve national CRC screening programmes? See the slides | Prof. Dr. Stephen Halloran, Screening specialist, Member of the Bowel Cancer Screening Advisory Committee, United Kingdom |
| 11:20 – 11:50 | Q & A | |
| 11:50 – 12:00 |
The Way Forward |
Zorana Maravic, Acting CEO, Digestive Cancers Europe (DiCE) |
Would you like more information? Please contact us.
